NGM BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 62921N905. A total of 2 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,159 | -61.4% | 10,100 | -39.2% | 0.00% | – |
| Q1 2023 | $67,728 | +693.6% | 16,600 | +876.5% | 0.00% | – |
| Q4 2022 | $8,534 | -86.7% | 1,700 | -65.3% | 0.00% | – |
| Q3 2022 | $64,000 | +2033.3% | 4,900 | +2350.0% | 0.00% | – |
| Q2 2022 | $3,000 | -98.2% | 200 | -97.8% | 0.00% | – |
| Q4 2021 | $163,000 | +328.9% | 9,200 | +411.1% | 0.00% | – |
| Q3 2021 | $38,000 | +5.6% | 1,800 | 0.0% | 0.00% | – |
| Q2 2021 | $36,000 | +500.0% | 1,800 | +800.0% | 0.00% | – |
| Q1 2021 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q4 2020 | $3,000 | -40.0% | 100 | -66.7% | 0.00% | – |
| Q3 2020 | $5,000 | -50.0% | 300 | -40.0% | 0.00% | – |
| Q2 2020 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $3,000 | 0.00% |